Charoen Pokphand Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Charoen Pokphand Indonesia Tbk trades at Rp3,070 (market cap 50.83T, 11.89M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Charoen Pokphand Indonesia Tbk is far larger — about 303.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Charoen Pokphand Indonesia Tbk is more actively traded (11.89M versus 71K). Which is the better fit depends on your goals.
| CPIN | OBAT | |
|---|---|---|
Market Cap | 50.83T | 167.37B |
Volume | 11.89M | 71K |
Lot | 118.87K | 710 |
Turnover | 36.7B | 17.51M |
Average Price | 3,087.87 | 246.63 |
Value | 36.7B | 17.51M |
Indicative Equilibrium Price | 3,070 | 246 |
Indicative Equilibrium Volume | 13.65K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.
Read more on CPIN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →